Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Equinor ASA (EQNR) Price & Performance

Amylx Pharmaceuticals IncTrade
Equinor ASATrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Equinor ASA — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Equinor ASA trades at $40.47 (market cap $97.58B). The key difference: Equinor ASA is far larger — about 37× Amylx Pharmaceuticals Inc's market cap, and Equinor ASA pays a 3.81% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMLXEQNR
Market Cap
$2.64B$97.58B
Sector
HealthEnergy
52-Week High
$24.19$42.40
52-Week Low
$7.82$22.41
Enterprise Value
$2.39B$106.28B
Dividend Yield
3.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.

Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.

Equinor ASA

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Equinor ASA

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

Read more on EQNR